Skip to content

Impact of mindfulness-based cognitive therapy (MBCT) on the levels of anxiety, depression, and subjective happiness in Russian first-year students of the Psychology Department

Anton Skolzkov

DOI: 10.31124/advance.12319667.v1 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Non-randomized controlled trial Pilot study
Sample size 107
Population First-year psychology students at the Ural Federal University named after B.N. Yeltsin
Intervention Mindfulness-based cognitive therapy (MBCT) program
Topics Anxiety Depression Meditation
Key findings MBCT reduced depression and increased subjective happiness among first-year psychology students.

Abstract

Social studies show an increasing number of people with anxiety disorders and depression around the world. Selected data on Russia confirm this trend. Despite the overall improvement in the world economic situation in recent decades, the stress level has not decreased. Freshmen are particularly vulnerable to stress. This pilot study assesses the mindfulness training effectiveness, which was aimed at maintaining mental and physical health of Russian students.

Participants: 107 freshmen of the Psychology Department of the Ural Federal University named after B.N. Yeltsin. The data collection was completed in November 2019.

Methods: A non-randomized controlled trial was conducted using Mindfulness-based cognitive therapy (MBCT) program.

Results: MBCT reduced depression and increased subjective happiness among the first-year psychology students. More frequent mindfulness meditation practice and the study of the theoretical materials are associated with higher rates of positive results of the program.

Conclusion: MBCT can be an effective program in working with first-year students of the Psychology Department of the Ural Federal University. Nevertheless, an additional research is required before putting the program into practice on a broad basis in Russian universities.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Explore topics